Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthias Preusser

Showing results (21-30 of 525) with videos related to

Pageof 53
Sort By:
Neuro-Oncology|November 15, 2024
Theranostics and molecular imaging in neuro-oncology: The beginning of a new eraNathalie L Albert, Matthias Preusser
Clinical Neuropathology|February 9, 2021
Reply to comment on "Analysis of the inflammatory tumor microenvironment in meningeal neoplasms"Anna S Berghoff, Matthias Preusser
Handbook of Clinical Neurology|January 11, 2012
CSF and laboratory analysis (tumor markers)Matthias Preusser, Johannes A Hainfellner
Current Opinion in Neurology|October 1, 2014
BRAF alterations in brain tumours: molecular pathology and therapeutic opportunitiesAnna Sophie Berghoff, Matthias Preusser
Handbook of Clinical Neurology|January 9, 2018
Role of the blood-brain barrier in metastatic disease of the central nervous systemAnna S Berghoff, Matthias Preusser
Neuro-Oncology|August 19, 2016
In search of a target: PD-1 and PD-L1 profiling across glioma typesAnna S Berghoff, Matthias Preusser
Current Treatment Options in Neurology|April 5, 2017
Targeted Therapies for Melanoma Brain MetastasesAnna S Berghoff, Matthias Preusser
Clinical Neuropathology|October 23, 2012
Clinical neuropathology practice guide 06-2012: MGMT testing in elderly glioblastoma patients--yes, but how?Anna S Berghoff, Matthias Preusser
Expert Review of Anticancer Therapy|October 31, 2013
Biology in prevention and treatment of brain metastasesAnna S Berghoff, Matthias Preusser
Future Oncology (London, England)|August 12, 2015
The future of targeted therapies for brain metastasesAnna S Berghoff, Matthias Preusser
Pageof 53

Showing results (21-30 of 525) with videos related to

Sort By:
Pageof 53
Neuro-Oncology|November 15, 2024
Theranostics and molecular imaging in neuro-oncology: The beginning of a new eraNathalie L Albert, Matthias Preusser
Clinical Neuropathology|February 9, 2021
Reply to comment on "Analysis of the inflammatory tumor microenvironment in meningeal neoplasms"Anna S Berghoff, Matthias Preusser
Handbook of Clinical Neurology|January 11, 2012
CSF and laboratory analysis (tumor markers)Matthias Preusser, Johannes A Hainfellner
Current Opinion in Neurology|October 1, 2014
BRAF alterations in brain tumours: molecular pathology and therapeutic opportunitiesAnna Sophie Berghoff, Matthias Preusser
Handbook of Clinical Neurology|January 9, 2018
Role of the blood-brain barrier in metastatic disease of the central nervous systemAnna S Berghoff, Matthias Preusser
Neuro-Oncology|August 19, 2016
In search of a target: PD-1 and PD-L1 profiling across glioma typesAnna S Berghoff, Matthias Preusser
Current Treatment Options in Neurology|April 5, 2017
Targeted Therapies for Melanoma Brain MetastasesAnna S Berghoff, Matthias Preusser
Clinical Neuropathology|October 23, 2012
Clinical neuropathology practice guide 06-2012: MGMT testing in elderly glioblastoma patients--yes, but how?Anna S Berghoff, Matthias Preusser
Expert Review of Anticancer Therapy|October 31, 2013
Biology in prevention and treatment of brain metastasesAnna S Berghoff, Matthias Preusser
Future Oncology (London, England)|August 12, 2015
The future of targeted therapies for brain metastasesAnna S Berghoff, Matthias Preusser
Pageof 53